| MeSH term | MeSH ID | Detail |
|---|---|---|
| Adenocarcinoma | D000230 | 166 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Colorectal Neoplasms | D015179 | 10 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Familial Mediterranean Fever | D010505 | 12 associated lipids |
| Zellweger Syndrome | D015211 | 39 associated lipids |
| Adenomatous Polyposis Coli | D011125 | 16 associated lipids |
| Adenomatous Polyps | D018256 | 4 associated lipids |
29623-28-7
29623-28-7 is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 1002 references associated with 29623-28-7 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 29623-28-7
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 29623-28-7
PubChem Associated disorders and diseases
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with 29623-28-7
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Liu W et al. | Ex vivo oxidation in tissue and plasma assays of hydroxyoctadecadienoates: Z,E/E,E stereoisomer ratios. | 2010 | Chem. Res. Toxicol. | pmid:20423158 |
| Imaizumi S et al. | L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice. | 2010 | Drug Metab Lett | pmid:20642447 |
| Yuan H et al. | 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer. | 2010 | Thorax | pmid:20388757 |
| Liu SH et al. | Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals. | 2010 | Br. J. Pharmacol. | pmid:20649594 |
| Shureiqi I et al. | Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis. | 2010 | Cancer Prev Res (Phila) | pmid:20570882 |
| Li MY et al. | Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer. | 2010 | Am. J. Respir. Cell Mol. Biol. | pmid:20081051 |
| Huang FC and Schwab W | Cloning and characterization of a 9-lipoxygenase gene induced by pathogen attack from Nicotiana benthamiana for biotechnological application. | 2011 | BMC Biotechnol. | pmid:21450085 |
| Cimen I et al. | 15-lipoxygenase-1 exerts its tumor suppressive role by inhibiting nuclear factor-kappa B via activation of PPAR gamma. | 2011 | J. Cell. Biochem. | pmid:21544861 |
| Kämmerer I et al. | 13-hydroxy linoleic acid increases expression of the cholesterol transporters ABCA1, ABCG1 and SR-BI and stimulates apoA-I-dependent cholesterol efflux in RAW264.7 macrophages. | 2011 | Lipids Health Dis | pmid:22129452 |
| Schneider C and Pozzi A | Cyclooxygenases and lipoxygenases in cancer. | 2011 | Cancer Metastasis Rev. | pmid:22002716 |